WEBINAR | Will the approval of one or more AD drug unleash the use of amyloid PET imaging?

Listen the webinar on demand and be part of the forefront of PET imaging in Alzheimer's disease

This interesting webinar delves into the current state of the art and future directions of PET imaging in Alzheimer’s disease.
With new Alzheimer's medications being approved recently, it is more important than ever to look at the perspectives of experts on the use and impact of PET imaging.

Prof. Dr. Henryk Barthel will share the European perspective on the challenges and opportunities related to anticipated approval of Alzheimer drugs in EU.

Prof. Dr. Henryk Barthel, Assistant Medical Director Brain PET and PET/MRI Department of Nuclear Medicine from the Leipzig University Medical Center

Duration: 20' followed by a live Q&A session 



Dr. Y. Fujibayashi will navigate through the regulatory landscape of amyloid PET imaging in Japan by giving you the current status and future directions.

Dr. Y. Fujibayashi, Chief Technology Officer, CMI

Duration: 20' followed by a live Q&A session